Citius Oncology (CTOR) Assets Average (2022 - 2026)

Citius Oncology's Assets Average history runs 5 years deep, the most recent figure standing at $105.3 million for Q1 2026.

• In Q1 2026, Assets Average rose 15.8% year-over-year to $105.3 million; the TTM figure through Mar 2026 stood at $105.3 million (up 15.8% YoY), while the FY2025 annual figure was $92.7 million, up 18.04% from the prior year.
• Assets Average was $105.3 million for Q1 2026 at Citius Oncology, roughly flat from $105.5 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $105.5 million in Q4 2025 to a low of $191583.5 in Q3 2022.
• Historically, Assets Average has averaged $69.6 million across 5 years, with a median of $68.5 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Assets Average jumped 30587.75% in 2023, then slipped 29.42% in 2024.
• A 5-year view of Assets Average shows it stood at $34.2 million in 2022, then jumped by 75.84% to $60.2 million in 2023, then jumped by 45.27% to $87.4 million in 2024, then gained by 20.63% to $105.5 million in 2025, then slipped by 0.12% to $105.3 million in 2026.
• The last three Assets Average figures came in at $105.3 million (Q1 2026), $105.5 million (Q4 2025), and $96.3 million (Q3 2025), per Business Quant data.